Date published: 2026-5-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

USP42 Activators

USP42, or Ubiquitin-Specific Protease 42, is part of the USP family of enzymes that play a crucial role in the process of deubiquitination, which is the removal of ubiquitin moieties from protein substrates. This process is essential for the regulation of protein degradation, signaling pathways, and cellular localization. USP42 Activators would thus represent a class of chemicals designed to enhance the deubiquitinating activity of USP42.

Direct USP42 Activators would be molecules that bind to the USP42 enzyme and induce a conformational change that either increases the enzyme's affinity for ubiquitin or enhances its catalytic efficiency in cleaving ubiquitin from protein substrates. This direct binding could occur at the enzyme's active site, facilitating the deubiquitination process, or at allosteric sites, which are separate from the active site but still capable of modulating the enzyme's activity. By stabilizing the active form of USP42 or by promoting interactions with substrates, these activators would enhance the functional role of USP42 in cellular processes. Indirect USP42 Activators, on the other hand, would not interact with the enzyme directly but would augment its activity by modifying the cellular environment or signaling pathways that influence USP42. These could include small molecules that upregulate the expression of the USP42 gene, leading to increased production of the enzyme. Other indirect activators may inhibit pathways responsible for the degradation of USP42, thus increasing its half-life and steady-state levels within the cell. Additionally, activators might induce post-translational modifications of USP42 that affect its stability, localization, or interaction with other proteins, thereby enhancing its deubiquitinating activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PR 619

2645-32-1sc-476324
sc-476324A
sc-476324B
1 mg
5 mg
25 mg
$77.00
$188.00
$431.00
1
(0)

PR-619 is a non-selective, broad-spectrum DUB inhibitor. By inhibiting the activity of other DUBs, PR-619 enhances USP42's role in deubiquitination, as there is an increased need for USP42's function.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is a proteasome inhibitor that increases the level of ubiquitinated proteins. This increase in ubiquitinated proteins enhances the role of USP42 in deubiquitination.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

Carfilzomib is another proteasome inhibitor. By increasing the levels of ubiquitinated proteins, it can enhance the deubiquitinating function of USP42.

P22077

1247819-59-5sc-478536
10 mg
$165.00
(0)

P22077 is a cell-permeable inhibitor that inhibits USP7 and USP47. Its inhibition of USP7 and USP47 indirectly enhances the functional activity of USP42 by increasing the demand for deubiquitinating activity.

WP1130

856243-80-6sc-364650
sc-364650A
10 mg
50 mg
$490.00
$1484.00
1
(0)

WP1130 is a selective deubiquitinase inhibitor that inhibits USP9x, USP5, USP14, and UCH37. By inhibiting these DUBs, WP1130 can increase the demand for deubiquitination activity, thereby enhancing the functional activity of USP42.

UCH-L1 Inhibitor Inhibitor

668467-91-2sc-356182
10 mg
$204.00
1
(1)

LDN-57444 is a reversible inhibitor of UCH-L1. Its inhibition of UCH-L1 indirectly enhances the functional activity of USP42 by increasing the demand for deubiquitinating activity.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine is recognized as an autophagy inhibitor that can lead to the accumulation of ubiquitinated proteins. This accumulation of ubiquitinated proteins can enhance the deubiquitinating function of USP42.